Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT sells care home operator Charleston to KOS and Primonial REIM

· EQT Infrastructure sells Charleston, a leading care home operator in Germany to Italian healthcare group KOS · EQT Infrastructure also sells Charleston’s real estate portfolio to Primovie, a European healthcare and educational focused real estate fund managed by Primonial REIM · During EQT Infrastructure‘s ownership, Charleston has pursued a buy-and-build strategy and today manages 47 homes; the real estate portfolio of Charleston includes 20 care homes The EQT Infrastructure II fund (“EQT” or “EQT Infrastructure”) has entered into a definitive agreement to sell Charleston

Conversion of shares

According to Husqvarna AB´s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in Husqvarna AB. When such a conversion has occurred, the company is obligated by the Act on Trading in Financial Instruments to disclose any such change. In July 2019, at the request of shareholders, 150 Class A shares were converted to Class B shares. The total number of votes thereafter amounts to 158,449,628.3. The total number of registered shares in the company amounts to 576,343,778 shares of

New number of votes in Beijer Alma AB

The number of votes in Beijer Alma AB has changed as a result of the conversion of a total of 5,000 Class A shares to 5,000 Class B shares. The conversion was conducted with the support of the option for Class A shareholders to request conversion of Class A shares to Class B shares that was entered into the Articles of Association at the 2015 Annual General Meeting.Following the conversion, there are a total of 60,262,200 registered shares of which 6,600,000 are Class A shares and 53,662,200 are Class B shares. As of July 31, 2019, the number of votes in the company amounts to 119,662,200

Change in number of shares and votes in ÅF Pöyry AB

The second opportunity to convert debentures into shares under the staff convertible debenture program decided by the Annual General Meeting 2016 was completed in July 2019. The numbers of B-shares and votes have increased by 115 608 through the conversion. Before the conversion: After the   conversion:A-shares: 4 290 336 A-shares: 4 290 336B-shares: 108 342 086 B-shares: 108 457 694Total   shares: 112 632 422 Total   shares: 112 748 030Votes: 151 245 446 Votes: 151 361 054 Please note that the numbers of

Increased number of shares and votes in Bergs Timber

In connection with the directed rights issue resolved by the Board on June 27 2019, on the basis of the issue authorization approved by the Annual General Meeting on May 8 2019, the number of shares and votes in Bergs Timber AB (publ) (“Bergs Timber”) increased by 5,940,594 during July. After completed registration of the shares the total number of shares and votes in Bergs Timber as of July 31 2019 totals 346,728,283. After the registration the share capital in Bergs Timber equals 346,728,283 SEK.     Further information on this press release can be provided by Peter Nilsson, President

Extraordinary shareholders’ meeting of Mentice AB

The shareholders in Mentice AB, reg. no. 556556-4241, are hereby invited to attend the extraordinary shareholders’ meeting to be held on Wednesday 28 August 2019 at 3.00 pm. at the company’s premises at Odinsgatan 10 in Gothenburg. Registration takes place from 2.00 pm.   Right to participate and notice Only shareholders who are recorded in their own name in the company’s share ledger kept by Euroclear Sweden AB (The Swedish Central Securities Depository Euroclear Sweden AB) as of Thursday 22 August 2019 have the right to participate in the shareholders’ meeting. Shareholders

Half-year Report Quartiers Properties – January to June 2019

Quartiers Properties AB (publ) (“Quartiers Properties” or “the company”) has today published the company’s half-year report for the January to June 2019 period.Summary of the period  · Net sales totalled SEK 56,389 thousand (SEK 3,242 thousand). The significant increase in net sales in the first half of the year was mainly due to sales of completed projects, which totalled SEK 49,234 thousand (0) during the period. In addition, revenues from the rental business also increased compared with the previous year. · Operating profit excluding changes in value was SEK 212 thousand,

Interim report 2018-09-01 - 2019-05-31

Third quarter report By "NextCell", “NXTCL” or "Company" is meant NextCell Pharma AB with organization number 556965-8361. “Spotlight" refers to the Spotlight Stock Market (previous AktieTorget). Amount in brackets refer to the corresponding period in the previous year. Note that the Company's fiscal year is September 1 - August 31. This English version is a translation of the Swedish version. The Swedish version is at all time to be seen as the leading document. Nine months (2018-09-01 until 2019-05-31) · Operating income amounted to SEK 1 410 055 (527 545). · Operating result

Change in the number of shares and votes in Q-linea AB

Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the month of July due to the new share issue carried out to ensure delivery of performance shares within the framework of the long-term incentive programme that was resolved by the annual general meeting on 22 May 2019. A total of 117,424 shares and votes have been added. At 31 July 2019, which is the last trading day in July, the number of shares and votes in the Company amounts to 23,235,387. All shares are ordinary shares.   For further information,

Change in number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, July 31st, 2019, Moberg Pharma AB (OMX: MOB). The number of shares and votes in Moberg Pharma AB (publ) (“Moberg Pharma”) has increased by 488,905 ordinary shares in July 2019. Therefore, there are in total 18,853,510 shares and votes in the company as of July 31st 2019, of which 18,192,667 are ordinary shares and 660,843 are shares of series B.The total number of shares and votes has increased as a result of 488,905 ordinary shares issued after exercise of warrants under Moberg Pharma’s share-based incentive program. Due to the exercise of the warrants, the total number of

CONVENING NOTICE FOR EXTRAORDINARY GENERAL MEETING IN RANPLAN GROUP AB

Ranplan Group AB (publ) publishes convening notice for extraordinary general meeting and proposes – on the basis of shareholders representing more than 70% of the outstanding votes – Tomas Isaksson, as a new ordinary member of the board, and the election of Prof. Jie Zhang, as new Chairman of the board, all effective after close of the EGM. In conjunction, Lars-Inge Sjöqvist, ordinary member of the board, and Mats Andersson, Chairman of the board, will step down subject to its approval at the EGM. Due to time constraints, Alastair Williamson, current CEO of Ranplan who will join Wyld Networks

Photocure ASA: Invitation to second quarter and first half year 2019 results presentation and webcast

Photocure will present its second quarter and first half year report on Wednesday 7 August 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).Representatives from the company will be Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English. The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com. It will be possible to follow the presentation through https://webtv.hegnar.no/presentation.php?webcastId=98041425  A light snack will be served from 08:00 (CET). The

Nomination committee propose new board members in Mentice AB prior to convening an Extraordinary Shareholders’ Meeting on August 28, 2019

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee proposes that the board be extended with three members to a total of seven members. The nomination committee intends to suggest the election of Denis Gestin, Gösta Johannesson and David Ballard. The nomination committee proposes that the extraordinary shareholders’ meeting resolves to approve and appoint three new board members to the board of directors. The board of directors propose that the following

Notice of Extraordinary General Meeting in Gunnebo AB (publ)

The shareholders of Gunnebo AB (publ), corporate ID No. 556438-2629, are hereby invited to attend the extraordinary general meeting (the ”EGM”) to be held on Monday, 26 August 2019 at 10.00 a.m. CEST, at Västsvenska Handelskammaren, Parkgatan 49 in Gothenburg, Sweden. Registration of attendance commences at 09.30 a.m. CEST.Right to attend A shareholder who wish to attend the EGM must: ·  be recorded in the share register for the company maintained by Euroclear Sweden AB, as of Tuesday, 20 August 2019, and ·  notify the company of its intention to attend the EGM by Tuesday, 20

Increased number of shares and votes in Hemfosa

The number of shares and votes in Hemfosa Fastigheter AB has increased as a result of a new share issue resolved upon by the board on July 3, 2019. The ordinary shares were used as payment in a property acquisition. Through the new share issue the number of ordinary shares and votes in the company increased by 1,760,000 ordinary shares and 1,760,000 votes. At the last trading day of July there were in total 180,488,248 shares in the company (169,488,249 ordinary shares and 10,999,999 preference shares) and 170,588,248.9 votes. For further information, please contact:   Caroline

Number of shares and votes in Calliditas Therapeutics

During July, the number of shares and votes in Calliditas Therapeutics AB (publ) (the “Company”) has increased due to the directed share issue of 3,505,291 new shares that the Company carried out in beginning of July, 2019. As of July 31, 2019, the number of shares and votes in the Company amounts to 38,707,638.For further information, please contact: Renée Aguiar-Lucander, CEO at Calliditas Email: renee.lucander@calliditas.com  Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications at Calliditas Email: mikael.widell@calliditas.com Telephone: +46 703 11 99 60

New number of shares in Handelsbanken

Due to an exchange of convertible notes in Svenska Handelsbanken AB, the number of Class A shares has increased by 3 901 900 shares and the number of votes has increased by 3 901 900.Following the increase, the total number of shares in Handelsbanken is 1 955 017 808  of which 1 919 766 479 are Class A shares and 35 251 329 are Class B shares. The total number of votes in Handelsbanken is 1 923 291 611,9. The share capital amounts to SEK 3 027 277 602,40 after the increase. For further information, please contact:Lars Höglund, Head of Investor Relations: +46 8–701 51 70,+46 70–345

Integrum is expanding in US

Integrum, the world leader in osseointegrated prosthetics for amputees was excited to announce its inaugural participation as an exhibitor at the 2019 Amputee Coalition’s National Conference in San Antonio, Texas held July 25th-27th, 2019. Integrum has been a gold sponsor to the American Amputee Coalition since January 2019. The American Amputee Coalition is a non-profit organization with more than 500 000 members dedicated to enhancing the quality of life for amputees and their families through support, education and advocacy. The Amputee Coalition’s National Conference provided

Increased number of shares and votes in Catena Media plc

The number of shares and votes in Catena Media plc amounts to 58,429,598 following a directed share issue of a total of 1,440,454 shares.Catena Media has, as announced on 16 July 2019 , resolved on a directed share issue of a total of 1,440,454 shares as a prepayment to the final earn-out payment for U.S. assets acquired in December 2016. The share issue has been registered with the Maltese authorities in July 2019.

Raute Corporation - Half-year report January 1 - June 30, 2019

RAUTE CORPORATION HALF-YEAR REPORT JULY 31, 2019 AT 9:00 a.m. This is a summary of Raute’s Half-year financial report January 1 – June 30, 2019. The complete report is attached to this release as a pdf file and is also available on the company’s’ website at www.raute.com.  RAUTE CORPORATION – HALF-YEAR REPORT JANUARY 1–JUNE 30, 2019  - The Group’s net sales, EUR 78.3 million (MEUR 78.9), decreased 0.8% from the comparison period. Order intake was EUR 58 million (MEUR 96).- Operating profit was EUR 4.9 million (MEUR 5.9), down 16% from the comparison period. The result before

Alligator Bioscience regains global rights from Janssen to CD40 agonistic antibody, ADC-1013 (JNJ-64457107)

Lund, Sweden, July 31, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that it has regained exclusive, worldwide rights from Janssen Biotech Inc. to develop and commercialize the CD40 agonistic antibody, ADC-1013 (JNJ-64457107), its lead tumor-directed immunotherapy candidate, in Phase I development for the treatment of metastatic cancer. The 2015 partnership agreement between Alligator and Janssen has been terminated as a result of a strategic portfolio decision by Janssen to prioritize other assets. Per Norlén, CEO of Alligator Bioscience, said: “Our ambition

Borr Drilling Limited Announces Pricing of Initial Public Offering in the United States

Hamilton, Bermuda — July 31, 2019 — Borr Drilling Limited (NYSE: BORR, OSE: BDRILL) (the "Company" or "Borr Drilling") today announced the pricing of its previously announced initial public offering in the United States of 5,000,000 of its common shares (the "Offering"), at a price to the public of $9.30 per common share (the "Offering Price"). Borr Drilling has also granted the underwriters of the Offering a 30-day option to purchase up to an additional 750,000 common shares at the Offering Price, less underwriting discounts and commissions. The Offering is expected to close on or about

Change of number of shares and votes in Green Landscaping Group AB (publ)

Pursuant to the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument), Swedish companies whose shares are listed on a regulated market and who increases or reduces the total number of shares or votes in the company is to disclose such changes on the last trading day the same month.As of 31 July 2019, there are in total 36 011 057 shares and votes in Green Landscaping Group AB (publ) (“Green” or the “Company”). The change in number of shares and votes in the Company is a result of the board of directors’ decision to issue in total 161 394

Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

Oslo, Norway, 31 July 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that the Company is invited to present at the Solebury Trout European Biotech Investor Day 2019 in NYC. Date: 1 August 2019Time: 10:30 AM EDTPresenter: Øystein Soug (CEO) The presentation will be available to download at www.targovax.com after the event.

There are no items matching the current filter
There are no more items matching the current filter
Back to top